Scientists tend not to be a sentimental lot, especially when it comes to antiqua ted equipment. If a device or technique becomes outmoded, it gets tossed onto the scrap heap. In a fast-moving field like genomics, 10-year-old equipment may as well be a century old, given what it's worth today. But the curators of 12 science museums are now saying, "Not so fast"-the out-with-the-old mentality could mean losing a piece of genomics history. So was born the Museum Genomics Initiative, in which museums are working together to acquire selected genomics instruments that have historic value. In a recent report on the initiative published in Nature News (http://www. nature.com/news/museums-hunt-forrelics-from-genomics-early-days-1.14287), museum curators describe some of their recent efforts, from salvaging a '90s-era colony-picking machine from MIT to creating an art display from old microarray slides. The goal of the initiative is to develop a prioritized list of pieces recommended for acquisition. Just don't ask what's on the list. According to the Nature report, Robert Bud, chief curator of medicine at the Science Museum, London, isn't saying-at least not publiclyfor fear of driving up the prices of items he'd like to acquire. So save those old PCR machines; your local science museum may want them.
-Karyn Hede, News Editor

Assisted reproduction and Prader-Willi syndrome see page 164
Assisted reproductive technology (ART), which enables couples having difficulty conceiving to bear children, is not without risk. The technology has been associated with an increased frequency of certain imprinting disorders. Gold et al. studied a cohort of children with Prader-Willi syndrome (PWS) and found that the use of ART by their parents did not seem to be higher than that for parents of other children. In an analysis of surveys completed by members of the Prader-Willi Syndrome Association, along with medical records, the research team determined that 1.1% of individuals with PWS were conceived using ART, compared with 1% of the general population, an insignificant difference. However, there was a significant difference in the cause of PWS among ART users. In this group, more cases were caused by maternal uniparental disomy (UPD) and imprinting defects than in the general population. The study is the first to report cases of an imprinting-center defect in PWS patients conceived via ART. The investigators suggest that the increase may be explained by the fact that the parents of those in the ART-conceived group were significantly older (mean age 36.3 and 39.7 years for mothers and fathers, respectively) than those of the naturally conceived group (31.5 and 31.6 years, respectively), and maternal UPD is associated with maternal age at conception. The age of parents using reproductive technologies must be taken into account when evaluating the risks associated with the technology. -Karyn Hede, News Editor
next-gen sequencing company reports clinical carrier screening technique see page 132
Next-generation DNA sequencing is poised to supplant traditional genotyping methods for many genetic screening applications. But before it can do so, the technique must jump the hurdles of speed, accuracy, and cost per test. Researchers from the clinical diagnostic company Good Start Genetics, based in Cambridge, Massachusetts, report that they have developed a proprietary method that can provide cost-efficient genotyping that is as accurate as traditional methods while providing more detailed information. Noting that accuracy and reproducibility have been an issue with previously described next-gen methods, the authors explain that the new method uses commercial sequencing technology combined with probes designed to capture regions of interest in 15 well-known recessive Mendelian disorders. The sample set of 194 yielded a single-nucleotide-variant false-positive rate of 1.1 per million base pairs and one false negative. The authors do not provide precise measurements of insertion/deletion detection accuracy but report a sensitivity of 95.3% in the reference set. The company has developed an automated workflow that processes the steps from isolating DNA from blood or cell lines to delivery of a clinical report within 6 days. Of course, next-gen methods are not yet appropriate for some types of mutations, including certain large deletions and chromosomal rearrangements, but for routine testing of common Mendelian disease traits, they are rapidly gaining ground. -Karyn Hede, News Editor research highlights ©American College of Medical Genetics and Genomics news briefs (continued) Human evolution just got more complicated
As amplification and sequencing technology become ever more adept at piecing together degraded ancient DNA, the ability to reach further into our own evolutionary past is within reach. But thus far those forays, rather than clarifying our ancestral heritage, have muddied the picture. Recent sequencing of DNA from fossils of early humans such as Denisovans (found in Siberia) and a hominid thought to be 400,000 years old has confused our understanding of early human migration. The so-called Sima de los Huesos fossil, named for the Spanish cave site where it was found, yielded mitochondrial DNA that indicates a closer relationship to Denisovans than to other humans or Neanderthals. Previously, anthropologists had thought Denisovans were restricted geographically to East Asia. The finding, published in Nature, simply adds to the mystery of who the Denisovans were and how they are related to other branches of the human family tree. The skeletons of these hominid ancestors resemble those of Neanderthals, but the new DNA evidence suggests a more complex story. The antiquity of the DNA sample, which is more than four times older than any human DNA previously sequenced, may point to a common ancestor of both Denisovans and Neanderthals or perhaps indicate interbreeding. The scientists hope to retrieve nuclear DNA from either this fossil or another at the same site to help clarify the picture, but acknowledge that it might not be possible to reconstruct a complete genome from DNA this old. A detailed explanation of the finding and a discussion of its implications can be found on science writer Carl Zimmer's blog (http://phenomena.nationalgeographic.com/2013/12/04/an-ancient-mysterious-scrap-of-human-dna).
-Karyn Hede, News Editor
Genetics in Medicine | Mission Statement
Genetics in Medicine is a monthly journal committed to the timely publication of:
• Original reports which enhance the knowledge and practice of medical genetics • Strategies and innovative approaches to the education of medical providers at all levels in the realm of genetics
As the official journal of the American College of Medical Genetics and Genomics (ACMG), the journal will:
• Provide a forum for discussion, debate and innovation concerning the changing and expanding role of medical genetics within the broader context of medicine • Fulfill our responsibility to the College membership through the publication of guidelines, policy statements and other information that enhances the practice and understanding of medical genetics Finally, as genetics becomes increasingly important in the wider medical arena, we will be an accessible and authoritative resource for the dissemination of medical genetic knowledge to providers outside of the genetics community through appropriate reviews, discussions, recommendations and guidelines.
